Selected research
Industry Growth & Trends
Global His-Tag Antibody Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global His-Tag Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for His-Tag Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the His-Tag Antibody market include Aviva Systems Biology, Bio X Cell, BioLegend, Cell Signaling Technology, Columbia Biosciences, GeneTex, Medimabs, NSJ Bioreagents and OriGene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global His-Tag Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The His-Tag Antibody market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global His-Tag Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to His-Tag Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global His-Tag Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
His-Tag Antibody Market by Company
Aviva Systems Biology
Bio X Cell
BioLegend
Cell Signaling Technology
Columbia Biosciences
GeneTex
Medimabs
NSJ Bioreagents
OriGene
Proteintech
Santa Cruz Biotechnology
United States Biological
His-Tag Antibody Segment by Type
Polyclonal
Monoclonal
His-Tag Antibody Segment by Application
Immunofluorescence
Immunoprecipitation
Western Blot
Others
His-Tag Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global His-Tag Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of His-Tag Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of His-Tag Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of His-Tag Antibody companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Immunofluorescence
- Immunoprecipitation
- Western Blot
- Others
Companies covered
- Aviva Systems Biology
- Bio X Cell
- BioLegend
- Cell Signaling Technology
- Columbia Biosciences
- GeneTex
- Medimabs
- NSJ Bioreagents
- OriGene
- Proteintech
- Santa Cruz Biotechnology
- United States Biological
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global His-Tag Antibody Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global His-Tag Antibody Market Size by Region (2021-2032)
- 1.4.1 Global His-Tag Antibody Market Size by Region (2021-2026)
- 1.4.2 Global His-Tag Antibody Market Size by Region (2027-2032)
- 1.5 Key Regions His-Tag Antibody Market Size (2021-2032)
- 1.5.1 North America His-Tag Antibody Market Size Growth Rate (2021-2032)
- 1.5.2 Europe His-Tag Antibody Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific His-Tag Antibody Market Size Growth Rate (2021-2032)
- 1.5.4 South America His-Tag Antibody Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa His-Tag Antibody Market Size Growth Rate (2021-2032)
2 His-Tag Antibody Market by Type
- 2.1 Type Introduction
- 2.1.1 Polyclonal
- 2.1.2 Monoclonal
- 2.2 Global His-Tag Antibody Market Size by Type
- 2.2.1 Global His-Tag Antibody Market Size Overview by Type (2021-2032)
- 2.2.2 Global His-Tag Antibody Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global His-Tag Antibody Market Size Forecasted by Type (2027-2032)
- 2.3 Global His-Tag Antibody Market Size by Regions
- 2.3.1 North America His-Tag Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe His-Tag Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific His-Tag Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America His-Tag Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa His-Tag Antibody Market Size Breakdown by Type (2021-2026)
3 His-Tag Antibody Market by Application
- 3.1 Type Introduction
- 3.1.1 Immunofluorescence
- 3.1.2 Immunoprecipitation
- 3.1.3 Western Blot
- 3.1.4 Others
- 3.2 Global His-Tag Antibody Market Size by Application
- 3.2.1 Global His-Tag Antibody Market Size Overview by Application (2021-2032)
- 3.2.2 Global His-Tag Antibody Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global His-Tag Antibody Market Size Forecasted by Application (2027-2032)
- 3.3 Global His-Tag Antibody Market Size by Regions
- 3.3.1 North America His-Tag Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe His-Tag Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific His-Tag Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America His-Tag Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa His-Tag Antibody Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 His-Tag Antibody Industry Trends
- 4.2 His-Tag Antibody Industry Drivers
- 4.3 His-Tag Antibody Industry Opportunities and Challenges
- 4.4 His-Tag Antibody Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by His-Tag Antibody Revenue (2021-2026)
- 5.2 Global His-Tag Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global His-Tag Antibody Key Company Headquarters & Area Served
- 5.4 Global His-Tag Antibody Company, Product Type & Application
- 5.5 Global His-Tag Antibody Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global His-Tag Antibody Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 His-Tag Antibody Players Market Share by Revenue in 2025
- 5.6.3 2025 His-Tag Antibody Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Aviva Systems Biology
- 6.1.1 Aviva Systems Biology Company Information
- 6.1.2 Aviva Systems Biology Business Overview
- 6.1.3 Aviva Systems Biology His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Aviva Systems Biology His-Tag Antibody Product Portfolio
- 6.1.5 Aviva Systems Biology Recent Developments
- 6.2 Bio X Cell
- 6.2.1 Bio X Cell Company Information
- 6.2.2 Bio X Cell Business Overview
- 6.2.3 Bio X Cell His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bio X Cell His-Tag Antibody Product Portfolio
- 6.2.5 Bio X Cell Recent Developments
- 6.3 BioLegend
- 6.3.1 BioLegend Company Information
- 6.3.2 BioLegend Business Overview
- 6.3.3 BioLegend His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BioLegend His-Tag Antibody Product Portfolio
- 6.3.5 BioLegend Recent Developments
- 6.4 Cell Signaling Technology
- 6.4.1 Cell Signaling Technology Company Information
- 6.4.2 Cell Signaling Technology Business Overview
- 6.4.3 Cell Signaling Technology His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Cell Signaling Technology His-Tag Antibody Product Portfolio
- 6.4.5 Cell Signaling Technology Recent Developments
- 6.5 Columbia Biosciences
- 6.5.1 Columbia Biosciences Company Information
- 6.5.2 Columbia Biosciences Business Overview
- 6.5.3 Columbia Biosciences His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Columbia Biosciences His-Tag Antibody Product Portfolio
- 6.5.5 Columbia Biosciences Recent Developments
- 6.6 GeneTex
- 6.6.1 GeneTex Company Information
- 6.6.2 GeneTex Business Overview
- 6.6.3 GeneTex His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GeneTex His-Tag Antibody Product Portfolio
- 6.6.5 GeneTex Recent Developments
- 6.7 Medimabs
- 6.7.1 Medimabs Company Information
- 6.7.2 Medimabs Business Overview
- 6.7.3 Medimabs His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Medimabs His-Tag Antibody Product Portfolio
- 6.7.5 Medimabs Recent Developments
- 6.8 NSJ Bioreagents
- 6.8.1 NSJ Bioreagents Company Information
- 6.8.2 NSJ Bioreagents Business Overview
- 6.8.3 NSJ Bioreagents His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 NSJ Bioreagents His-Tag Antibody Product Portfolio
- 6.8.5 NSJ Bioreagents Recent Developments
- 6.9 OriGene
- 6.9.1 OriGene Company Information
- 6.9.2 OriGene Business Overview
- 6.9.3 OriGene His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 OriGene His-Tag Antibody Product Portfolio
- 6.9.5 OriGene Recent Developments
- 6.10 Proteintech
- 6.10.1 Proteintech Company Information
- 6.10.2 Proteintech Business Overview
- 6.10.3 Proteintech His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Proteintech His-Tag Antibody Product Portfolio
- 6.10.5 Proteintech Recent Developments
- 6.11 Santa Cruz Biotechnology
- 6.11.1 Santa Cruz Biotechnology Company Information
- 6.11.2 Santa Cruz Biotechnology Business Overview
- 6.11.3 Santa Cruz Biotechnology His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Santa Cruz Biotechnology His-Tag Antibody Product Portfolio
- 6.11.5 Santa Cruz Biotechnology Recent Developments
- 6.12 United States Biological
- 6.12.1 United States Biological Company Information
- 6.12.2 United States Biological Business Overview
- 6.12.3 United States Biological His-Tag Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 United States Biological His-Tag Antibody Product Portfolio
- 6.12.5 United States Biological Recent Developments
7 North America
- 7.1 North America His-Tag Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America His-Tag Antibody Market Size by Country (2021-2026)
- 7.3 North America His-Tag Antibody Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe His-Tag Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe His-Tag Antibody Market Size by Country (2021-2026)
- 8.3 Europe His-Tag Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific His-Tag Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific His-Tag Antibody Market Size by Country (2021-2026)
- 9.3 Asia-Pacific His-Tag Antibody Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America His-Tag Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America His-Tag Antibody Market Size by Country (2021-2026)
- 10.3 South America His-Tag Antibody Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa His-Tag Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa His-Tag Antibody Market Size by Country (2021-2026)
- 11.3 Middle East & Africa His-Tag Antibody Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst